Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 505

1.

Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor.

Konishi K, Miyake T, Furukawa S, Senba H, Kanzaki S, Nakaguchi H, Yukimoto A, Nakamura Y, Watanabe T, Koizumi Y, Yoshida O, Tokumoto Y, Hirooka M, Kumagi T, Abe M, Matsuura B, Hiasa Y.

Atherosclerosis. 2020 Mar 7;299:32-37. doi: 10.1016/j.atherosclerosis.2020.02.026. [Epub ahead of print]

PMID:
32203743
2.

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Hiraoka A, Kumada T, Fukunishi S, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Yokohama K, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K, Kudo M.

Liver Cancer. 2020 Jan;9(1):73-83. doi: 10.1159/000503031. Epub 2019 Oct 18.

3.

Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.

Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Yasuda S, Toyoda H, Fukunishi S, Ohama H, Kawata K, Nakamura S, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y.

Liver Int. 2020 Feb 17. doi: 10.1111/liv.14405. [Epub ahead of print]

PMID:
32064740
4.

Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis.

Hagihara M, Kuroki Y, Ariyoshi T, Higashi S, Fukuda K, Yamashita R, Matsumoto A, Mori T, Mimura K, Yamaguchi N, Okada S, Nonogaki T, Ogawa T, Iwasaki K, Tomono S, Asai N, Koizumi Y, Oka K, Yamagishi Y, Takahashi M, Mikamo H.

iScience. 2020 Jan 24;23(1):100772. doi: 10.1016/j.isci.2019.100772. Epub 2019 Dec 13.

5.

Antibacterial effect of indene on Helicobacter pylori correlates with specific interaction between its compound and dimyristoyl-phosphatidylethanolamine.

Wanibuchi K, Takezawa M, Hosoda K, Amgalanbaatar A, Tajiri K, Koizumi Y, Niitsu S, Masui H, Sakai Y, Shoji M, Takahashi T, Hirai Y, Shimomura H.

Chem Phys Lipids. 2020 Mar;227:104871. doi: 10.1016/j.chemphyslip.2020.104871. Epub 2020 Jan 7.

PMID:
31923389
6.

Survival of a case of Bacillus cereus meningitis with brain abscess presenting as immune reconstitution syndrome after febrile neutropenia - a case report and literature review.

Koizumi Y, Okuno T, Minamiguchi H, Hodohara K, Mikamo H, Andoh A.

BMC Infect Dis. 2020 Jan 6;20(1):15. doi: 10.1186/s12879-019-4753-1. Review.

7.

[Performance Evaluation of "BinaxNOW™ Streptococcus pneumoniae" Using Alere™ Reader].

Ohno T, Suematsu H, Nakamura A, Kawamoto Y, Miyazaki N, Sakanashi D, Yamada A, Koita I, Watanabe H, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.

Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2019 Dec 25;29(1):11-17. Japanese.

PMID:
31856573
8.

The clinical characteristics of Acinetobacter bacteremia differ among genomospecies: A hospital-based retrospective comparative analysis of genotypically identified strains.

Koizumi Y, Sakanashi D, Ohno T, Yamada A, Shiota A, Kato H, Hagihara M, Watanabe H, Asai N, Watarai M, Murotani K, Yamagishi Y, Suematsu H, Mikamo H.

J Microbiol Immunol Infect. 2019 Dec;52(6):966-972. doi: 10.1016/j.jmii.2019.09.007. Epub 2019 Oct 30.

9.

Reoperation Rates after Laminoplasty for Cervical Disorders: A 26-Year Period Survival Function Method Analysis.

Hashimoto K, Aizawa T, Ozawa H, Tanaka Y, Kusakabe T, Morozumi N, Koizumi Y, Sato T, Hyodo H, Nakagawa T, Takahashi E, Hoshikawa T, Imaizumi H, Ogawa S, Kasama F, Kanno H, Itoi E, Kokubun S.

Spine Surg Relat Res. 2019 Jul 10;3(4):304-311. doi: 10.22603/ssrr.2019-0028. eCollection 2019.

10.

Authors' Response to "Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis".

Koizumi Y, Hirooka M, Tanaka T, Sunago K, Yukimoto A, Imai Y, Watanabe T, Ishihara T, Yoshida O, Yamamoto Y, Takeshita E, Ikeda Y, Abe M, Hiasa Y.

Intern Med. 2020 Mar 15;59(6):883. doi: 10.2169/internalmedicine.3886-19. Epub 2019 Nov 22. No abstract available.

11.

In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains.

Hagihara M, Kato H, Yamashita R, Soda M, Watanabe H, Sakanashi D, Shiota A, Asai N, Koizumi Y, Suematsu H, Yamagishi Y, Kitaichi K, Mikamo H.

J Infect Chemother. 2020 Jan;26(1):1-7. doi: 10.1016/j.jiac.2019.10.014. Epub 2019 Nov 15.

PMID:
31735629
12.

[PREVALENCE OF FUNCTIONAL DYSPEPSIA SYMPTOMS IN PATIENTS WITH ASTHMA].

Tomyo F, Sugimoto N, Toyota H, Ito A, Ujino M, Sakasegawa H, Kobayashi K, Koizumi Y, Miyoshi S, Kuramochi M, Yamaguchi M, Yamamoto T, Nagase H.

Arerugi. 2019;68(9):1132-1140. doi: 10.15036/arerugi.68.1132. Japanese.

PMID:
31723110
13.

A survey of public attitudes toward uterus transplantation, surrogacy, and adoption in Japan.

Nakazawa A, Hirata T, Arakawa T, Nagashima N, Fukuda S, Neriishi K, Harada M, Hirota Y, Koga K, Wada-Hiraike O, Koizumi Y, Fujii T, Irahara M, Osuga Y.

PLoS One. 2019 Oct 30;14(10):e0223571. doi: 10.1371/journal.pone.0223571. eCollection 2019.

14.

Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.

Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y.

Hepatol Res. 2020 Jan;50(1):75-83. doi: 10.1111/hepr.13427. Epub 2019 Dec 6.

PMID:
31660700
15.

Retrospective study on clinical efficacy and safety for daptomycin intermittent doses with or without loading dose in renal failure patients.

Kato H, Hagihara M, Shibata Y, Asai N, Koizumi Y, Watarai M, Yamagishi Y, Mikamo H.

J Infect Chemother. 2020 Mar;26(3):215-224. doi: 10.1016/j.jiac.2019.09.004. Epub 2019 Sep 28.

PMID:
31575501
16.

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K; On behalf of the Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Oncology. 2019;97(6):334-340. doi: 10.1159/000502095. Epub 2019 Aug 29.

PMID:
31466068
17.

New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode.

Koizumi Y, Hirooka M, Tamaki N, Yada N, Nakashima O, Izumi N, Kudo M, Hiasa Y.

PLoS One. 2019 Aug 27;14(8):e0221548. doi: 10.1371/journal.pone.0221548. eCollection 2019.

18.

Relationship between cytopenia and gestational age in infants and neonates treated with linezolid therapy.

Shibata Y, Hagihara M, Kato H, Asai N, Koizumi Y, Watarai M, Suematsu H, Yamagishi Y, Mikamo H.

J Infect Chemother. 2020 Jan;26(1):95-100. doi: 10.1016/j.jiac.2019.07.022. Epub 2019 Aug 23.

PMID:
31447138
19.

Correction to: Validation trial for efficacy of ultrasonographic measurement method to predict ascitic volume using virtual ultrasonography.

Hirooka M, Koizumi Y, Imai Y, Yukimoto A, Watanabe T, Yoshida O, Abe M, Hiasa Y.

J Med Ultrason (2001). 2019 Oct;46(4):519. doi: 10.1007/s10396-019-00966-y.

PMID:
31372792
20.

Comparison of the in Vivo Activities of Garenoxacin and Levofloxacin in a Murine Model of Pneumonia by Mixed-Infection with Streptococcus pneumoniae and Parvimonas micra.

Kato H, Hagihara M, Yokoyama Y, Suematsu H, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.

Jpn J Infect Dis. 2019 Nov 21;72(6):407-412. doi: 10.7883/yoken.JJID.2019.109. Epub 2019 Jul 31.

21.

The SOFA score could predict the severity and prognosis of infective endocarditis.

Asai N, Shiota A, Ohashi W, Watanabe H, Shibata Y, Kato H, Sakanashi D, Hagihara M, Koizumi Y, Yamagishi Y, Suematsu H, Mikamo H.

J Infect Chemother. 2019 Dec;25(12):965-971. doi: 10.1016/j.jiac.2019.05.014. Epub 2019 Jul 15.

PMID:
31320197
22.

Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease.

Hirooka M, Ochi H, Hiraoka A, Koizumi Y, Tanaka T, Sunago K, Yukimoto A, Imai Y, Watanabe T, Yoshida O, Abe M, Joko K, Michitaka K, Hiasa Y.

J Gastroenterol Hepatol. 2020 Feb;35(2):299-304. doi: 10.1111/jgh.14786. Epub 2019 Aug 16.

PMID:
31318996
23.

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Tanaka H, Tamai T, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Oncology. 2019;97(5):277-285. doi: 10.1159/000501281. Epub 2019 Jul 15.

PMID:
31307035
24.

Discovery of a pyrazolo[1,5-a]pyrimidine derivative (MT-3014) as a highly selective PDE10A inhibitor via core structure transformation from the stilbene moiety.

Koizumi Y, Tanaka Y, Matsumura T, Kadoh Y, Miyoshi H, Hongu M, Takedomi K, Kotera J, Sasaki T, Taniguchi H, Watanabe Y, Takakuwa M, Kojima K, Baba N, Nakamura I, Kawanishi E.

Bioorg Med Chem. 2019 Aug 1;27(15):3440-3450. doi: 10.1016/j.bmc.2019.06.021. Epub 2019 Jun 19.

PMID:
31235264
25.

Selective Synthesis of Primary Anilines from NH3 and Cyclohexanones by Utilizing Preferential Adsorption of Styrene on the Pd Nanoparticle Surface.

Koizumi Y, Jin X, Yatabe T, Miyazaki R, Hasegawa JY, Nozaki K, Mizuno N, Yamaguchi K.

Angew Chem Int Ed Engl. 2019 Aug 5;58(32):10893-10897. doi: 10.1002/anie.201903841. Epub 2019 Jul 5.

PMID:
31184798
26.

Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma.

Koizumi Y, Hirooka M, Hiraoka A, Ochi H, Tanaka T, Yukimoto A, Imai Y, Watanabe T, Yoshida O, Miyake T, Matsuura B, Michitaka K, Joko K, Abe M, Hiasa Y.

Endocr J. 2019 Sep 28;66(9):787-792. doi: 10.1507/endocrj.EJ19-0140. Epub 2019 May 30.

27.

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Cancer Med. 2019 Jul;8(8):3719-3728. doi: 10.1002/cam4.2241. Epub 2019 May 24.

28.

Schistosomiasis Diagnosed Using Laparoscopy and Colonoscopy.

Koizumi Y, Hirooka M, Tanaka T, Sunago K, Yukimoto A, Imai Y, Watanabe T, Ishihara T, Yoshida O, Yamamoto Y, Takeshita E, Ikeda Y, Abe M, Hiasa Y.

Intern Med. 2019 Sep 1;58(17):2495-2499. doi: 10.2169/internalmedicine.2776-19. Epub 2019 May 22.

29.

Clinical manifestations and risk factors of community-onset Acinetobacter species pneumonia in Japan; case control study in a single institute in Japan.

Asai N, Sakanashi D, Suematsu H, Kato H, Watanabe H, Shiota A, Hagihara M, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 Aug;25(8):639-642. doi: 10.1016/j.jiac.2019.03.016. Epub 2019 Apr 30.

PMID:
31053537
30.

Extended drip infusion of peripheral parental nutrition containing amino acids might be associated with Bacillus cereus bloodstream infection.

Shiota A, Asai N, Koizumi Y, Watanabe H, Sakata M, Kurumiya A, Takahashi T, Muramatsu Y, Hagihara M, Suematsu H, Yamagishi Y, Mikamo H.

Am J Infect Control. 2019 Sep;47(9):1154-1156. doi: 10.1016/j.ajic.2019.02.020. Epub 2019 Apr 30.

PMID:
31047689
31.

Infective endocarditis caused by Cardiobacterium hominis endocarditis: A case report and review of the literature.

Asai N, Sakanashi D, Suematsu H, Nishiyama N, Watanabe H, Kato H, Shiota A, Hagihara M, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 Aug;25(8):626-629. doi: 10.1016/j.jiac.2019.02.002. Epub 2019 Apr 28.

PMID:
31043327
32.

Efficacy and accuracy of qSOFA and SOFA scores as prognostic tools for community-acquired and healthcare-associated pneumonia.

Asai N, Watanabe H, Shiota A, Kato H, Sakanashi D, Hagihara M, Koizumi Y, Yamagishi Y, Suematsu H, Mikamo H.

Int J Infect Dis. 2019 Jul;84:89-96. doi: 10.1016/j.ijid.2019.04.020. Epub 2019 Apr 24.

33.

Brevibacterium paucivorans bacteremia: case report and review of the literature.

Asai N, Suematsu H, Yamada A, Watanabe H, Nishiyama N, Sakanashi D, Kato H, Shiota A, Hagihara M, Koizumi Y, Yamagishi Y, Mikamo H.

BMC Infect Dis. 2019 Apr 25;19(1):344. doi: 10.1186/s12879-019-3962-y.

34.

Chip-based digital polymerase chain reaction technology is useful for monitoring the JAK2 V617F allele burden in Philadelphia-negative myeloproliferative neoplasms.

Furuya D, Moriai M, Murai R, Moriai R, Koizumi Y, Endo T, Asanuma K, Yanagihara N, Takahashi S.

Int J Lab Hematol. 2019 Oct;41(5):e113-e116. doi: 10.1111/ijlh.13013. Epub 2019 Mar 23. No abstract available.

PMID:
30903743
35.

Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation.

Hiraoka A, Hirooka M, Ochi H, Koizumi Y, Izumoto H, Ueki H, Tsuruta M, Ono A, Yoshino T, Aibiki T, Okudaira T, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Kishida M, Tsubouchi E, Abe M, Matsuura B, Ninomiya T, Joko K, Kawasaki H, Hiasa Y, Michitaka K.

Oncology. 2019;96(5):242-251. doi: 10.1159/000496225. Epub 2019 Mar 20.

PMID:
30893698
36.

Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.

Furuya D, Moriai M, Koizumi Y, Endo T, Asanuma K, Yanagihara N, Takahashi S.

Int J Clin Oncol. 2019 Jul;24(7):871-875. doi: 10.1007/s10147-019-01419-9. Epub 2019 Feb 23.

PMID:
30798394
37.

A novel disk-based detection method with superior sensitivity for β-lactamase production in third-generation cephalosporin-resistant Enterobacteriaceae.

Sakanashi D, Miyazaki N, Kawamoto Y, Ohno T, Yamada A, Koita I, Suematsu H, Hagihara M, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 May;25(5):330-336. doi: 10.1016/j.jiac.2018.12.008. Epub 2019 Feb 21.

PMID:
30797690
38.

Clostridioides difficile-related toxic megacolon after Cryptococcus neoformans cellulitis: A complex of two rare infections in an immunocompromised host.

Koizumi Y, Kachi A, Tsuboi K, Muto J, Watanabe H, Asai N, Nobata H, Shiota A, Kato H, Sakanashi D, Hagihara M, Yamagishi Y, Suematsu H, Banno S, Mikamo H.

J Infect Chemother. 2019 May;25(5):379-384. doi: 10.1016/j.jiac.2018.12.003. Epub 2019 Feb 21.

PMID:
30797689
39.

Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation.

Imai Y, Yoshida O, Watanabe T, Yukimoto A, Koizumi Y, Ikeda Y, Tokumoto Y, Hirooka M, Abe M, Hiasa Y.

PLoS One. 2019 Feb 22;14(2):e0212589. doi: 10.1371/journal.pone.0212589. eCollection 2019.

40.

Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature.

Asai N, Koizumi Y, Yamada A, Sakanashi D, Watanabe H, Kato H, Shiota A, Hagihara M, Suematsu H, Yamagishi Y, Mikamo H.

J Med Case Rep. 2019 Feb 13;13(1):33. doi: 10.1186/s13256-019-1969-z. Review.

41.

Genome-Scale CRISPR/Cas9 Screening Reveals Squalene Epoxidase as a Susceptibility Factor for Cytotoxicity of Malformin A1.

Koizumi Y, Fukushima J, Kobayashi Y, Kadowaki A, Natsui M, Yamaguchi T, Imai Y, Sugiyama T, Kuba K.

Chembiochem. 2019 Jun 14;20(12):1563-1568. doi: 10.1002/cbic.201800769. Epub 2019 Apr 18.

42.

A severe case of Streptococcal pyogenes empyema following influenza A infection.

Asai N, Suematsu H, Sakanashi D, Kato H, Hagihara M, Watanabe H, Shiota A, Koizumi Y, Yamagishi Y, Mikamo H.

BMC Pulm Med. 2019 Jan 28;19(1):25. doi: 10.1186/s12890-019-0787-9.

43.

The C-Reactive Protein/Albumin Ratio Is Useful for Predicting Short-Term Survival in Cancer and Noncancer Patients.

Miyamoto T, Fujitani M, Fukuyama H, Hatanaka S, Koizumi Y, Kawabata A.

J Palliat Med. 2019 May;22(5):532-537. doi: 10.1089/jpm.2018.0404. Epub 2018 Dec 20.

PMID:
30570426
44.

Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.

Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Michitaka K, Deguchi A, Ishikawa T, Imai M, Ochi H, Joko K, Shimada N, Tajiri K, Hirooka M, Koizumi Y, Hiasa Y, Tanaka J.

J Gastroenterol Hepatol. 2019 Jun;34(6):1066-1073. doi: 10.1111/jgh.14564. Epub 2019 Feb 27.

PMID:
30549320
45.

Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital.

Sakagami T, Kawano T, Yamashita K, Yamada E, Fujino N, Kaeriyama M, Fukuda Y, Nomura N, Mitsuyama J, Suematsu H, Watanabe H, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 Jan;25(1):34-40. doi: 10.1016/j.jiac.2018.10.007. Epub 2018 Nov 3.

PMID:
30401513
46.

Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma.

Yukimoto A, Hirooka M, Hiraoka A, Michitaka K, Ochi H, Joko K, Imai Y, Watanabe T, Koizumi Y, Yoshida O, Abe M, Hiasa Y.

Jpn J Clin Oncol. 2019 Jan 1;49(1):42-47. doi: 10.1093/jjco/hyy153.

PMID:
30380075
47.

Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma.

Hirooka M, Ochi H, Hiraoka A, Koizumi Y, Matsuura B, Joko K, Michitaka K, Abe M, Hiasa Y.

Intern Med. 2019 Mar 15;58(6):791-795. doi: 10.2169/internalmedicine.1874-18. Epub 2018 Oct 17.

48.

Reduction of response time by data placement reflecting co-occurrence structures in structured overlay networks.

Koizumi Y, Watabe K, Nakagawa K.

PLoS One. 2018 Oct 12;13(10):e0205757. doi: 10.1371/journal.pone.0205757. eCollection 2018.

49.

Antimicrobial activity of solithromycin and levofloxacin against a murine pneumonia mixed-infection model caused by Streptococcus pneumoniae and anaerobic bacteria.

Kato H, Yamagishi Y, Hagihara M, Yokoyama Y, Suematsu H, Asai N, Koizumi Y, Mikamo H.

J Infect Chemother. 2019 Apr;25(4):311-313. doi: 10.1016/j.jiac.2018.09.003. Epub 2018 Oct 2.

PMID:
30287186
50.

IL-9 Blockade Suppresses Silica-induced Lung Inflammation and Fibrosis in Mice.

Sugimoto N, Suzukawa M, Nagase H, Koizumi Y, Ro S, Kobayashi K, Yoshihara H, Kojima Y, Kamiyama-Hara A, Hebisawa A, Ohta K.

Am J Respir Cell Mol Biol. 2019 Feb;60(2):232-243. doi: 10.1165/rcmb.2017-0287OC.

PMID:
30240278

Supplemental Content

Loading ...
Support Center